Kidney patients needed to test new Drug's safety
NCT ID NCT06723535
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 25 times
Summary
This study tested a single dose of the drug BMS-986278 in 27 people: some with healthy kidneys, some with severe kidney disease, and some on dialysis. The goal was to see how kidney problems affect drug levels and safety. Results will help doctors decide the right dose for future patients with kidney issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0002
Miami, Florida, 33147-4040, United States
-
Local Institution - 0003
Miami, Florida, 33172, United States
-
Local Institution - 0004
Orlando, Florida, 32808-7820, United States
-
Orlando Clinical Research Center
Orlando, Florida, 32809-3017, United States
Conditions
Explore the condition pages connected to this study.